| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2022 | CPIX Cumberland Pharmaceuticals Inc | Young Caroline52 | Director | Buy | 626 | $2.43 | $1,523.96 | +0.1% | -3.7% | -22.0% | |
| Sep 27, 2022 | CPIX Cumberland Pharmaceuticals Inc | Jones James53 | Director | Buy | 976 | $2.44 | $2,376.72 | +0.1% | -3.7% | -22.0% | |
| Sep 27, 2022 | CPIX Cumberland Pharmaceuticals Inc | Galante Joseph C47 | Director | Buy | 1,990 | $2.44 | $4,850.85 | +0.1% | -3.7% | -22.0% | |
| Sep 27, 2022 | CPIX Cumberland Pharmaceuticals Inc | Krogulski Kenneth54 | Director | Buy | 3,280 | $2.44 | $7,996.35 | - | -3.7% | -22.0% | |
| Sep 26, 2022 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 23,700 | $1.34 | $31,852.80 | - | - | - | |
| Sep 26, 2022 | CBSTF Cannabist Co Holdings Inc. | Watson Derek | Chief Financial Officer | Buy | 5,000 | $1.31 | $6,532.50 | +100.0% | - | - | |
| Sep 23, 2022 | TSNDF Terrascend Corp. | Collard Craig A | Director | Buy | 60,000 | $0.00 | - | +16.6% | - | - | |
| Sep 22, 2022 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $203.34 | $1,220,047.55 | -5.0% | +31.6% | +7.1% | |
| Sep 22, 2022 | ETON Eton Pharmaceuticals, Inc. | Brynjelsen Sean | Chief Executive Officer | Buy | 10,000 | $2.10 | $21,042.00 | +1.0% | +33.2% | +113.8% | |
| Sep 22, 2022 | TSNDF Terrascend Corp. | Collard Craig A | Director | Buy | 120,000 | $0.00 | - | +49.8% | - | - | |
| Sep 22, 2022 | PLNH Planet 13 Holdings Inc. | Jennings Michael Lanteri | Pres. Of East Coast Operations | Sell | 75,650 | $1.22 | $92,597.39 | -1.5% | - | - | |
| Sep 20, 2022 | BMY Bristol Myers Squibb Co | Caforio Giovanni59 | Board Chair And CEO | Sell | 25,000 | $69.71 | $1,742,750.00 | -5.0% | +5.7% | -15.1% | |
| Sep 20, 2022 | HIMS Hims & Hers Health, Inc. | O'Keefe Lynne Chou | Director | Sell | 10,046 | $5.68 | $57,061.28 | -100% | +17.0% | +8.2% | |
| Sep 20, 2022 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 10,668 | $5.68 | $60,594.24 | -60.5% | +17.0% | +8.2% | |
| Sep 19, 2022 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L.60 | President And CEO | Sell | 3,394 | $6.94 | $23,547.57 | -1.7% | -20.8% | -83.4% | |
| Sep 19, 2022 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 255 | $6.92 | $1,764.86 | -0.5% | -20.8% | -83.4% | |
| Sep 15, 2022 | COLL Collegium Pharmaceutical, Inc | Kuhlmann Shirley R.49 | EVP And General Counsel | Sell | 38,589 | $18.07 | $697,303.23 | -26.1% | +25.3% | +25.2% | |
| Sep 15, 2022 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 386 | $85.83 | $33,130.38 | -0.6% | -34.5% | -22.0% | |
| Sep 15, 2022 | BMY Bristol Myers Squibb Co | Caforio Giovanni59 | Board Chair And CEO | Sell | 50,000 | $71.84 | $3,592,000.00 | -9.1% | +8.3% | -17.1% | |
| Sep 14, 2022 | BMY Bristol Myers Squibb Co | Powell Ann64 | EVP, Chief Human Resources | Sell | 25,000 | $70.75 | $1,768,750.00 | -33.1% | +10.6% | -14.9% | |
| Sep 13, 2022 | BMY Bristol Myers Squibb Co | Elkins David V | EVP, Chief Financial Officer | Sell | 133,951 | $71.30 | $9,551,166.79 | -37.8% | +11.9% | -15.4% | |
| Sep 13, 2022 | LQDA Liquidia Corp | Kaseta Michael57 | Chief Financial Officer | Buy | 8,000 | $5.99 | $47,920.00 | +26.8% | +6.9% | +17.6% | |
| Sep 12, 2022 | VRNO Verano Holdings Corp. | Summerer Brett Andrew | Chief Financial Officer | Sell | 5,168 | $6.28 | $32,448.58 | -66.7% | - | - | |
| Sep 9, 2022 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 11,002 | $6.64 | $73,053.28 | -80.2% | +8.5% | -2.2% | |
| Sep 9, 2022 | ELAN Elanco Animal Health Inc | Hoover R David50 | Director | Buy | 20,000 | $15.18 | $303,614.00 | +16.0% | -16.3% | -22.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.